SIGA Technologies, Inc., Corvallis, Oregon 97330
Received 20 May 2005/ Returned for modification 14 September 2005/ Accepted 26 October 2005
| ABSTRACT |
|---|
|
|
|---|
| TEXT |
|---|
|
|
|---|
Recently, HtrA was reported to be necessary for survival of Listeria monocytogenes 10403S in elevated NaCl concentrations, for high-temperature growth (44°C), and for resistance to oxidative damage caused by hydrogen peroxide (24). In additional studies, L. monocytogenes EGDe HtrA was found to be involved in sensitivity to acid conditions (pH 5) and penicillin G-induced stress and was necessary for efficient colonization of spleens of BALB/c mice (22). In order to gain further understanding of the role of HtrA in L. monocytogenes physiology and pathogenesis and to provide support for the hypothesis that HtrA protease is a valid target for a novel class of anti-infectives for gram-positive organisms, further characterization of the phenotype of an L. monocytogenes 10403s htrA mutant was initiated.
An in-frame deletion of the L. monocytogenes htrA gene was constructed. Primers RW9 (5'-CCGCAAGGCTTTTTCAAACGATAGGGC-3') and RW11 (5'-CGGGGTACCTAAAGTATCCTCGACCTCTCTTTTCGG-3') and primers RW12 (5'-CCGGGTACCGCAGCAATCAATCCAGGTAAC-3') and RW10 (5'-CCGGAATTCACCCTCTTTTTCAAGAGAATG-3') (IDT, Iowa City, IA) were used to PCR amplify the 5' and 3' regions of htrA by using L. monocytogenes 10403S (18) chromosomal DNA (DNeasy Tissue Kit, QIAGEN, Valencia, CA) as a template. The PCR products were introduced into plasmid pCR2.1 (Invitrogen, Carlsbad, CA), forming plasmids pCR-htrA5' and pCR-htrA3'. pCR-htrA3' was digested with PstI and EcoRI, and the resulting 524-bp fragment was ligated to PstI-EcoRI-digested pKSV7 (21). A 542-bp BamHI-KpnI product from pCR-htrA-5' was subsequently introduced into this plasmid, forming plasmid pKSV-htrA
. This plasmid created an in-frame deletion of the htrA gene that encodes the first 40 N-terminal amino acids and the last 166 C-terminal amino acids of the predicted 542-amino-acid HtrA protein. Integration of temperature-sensitive plasmid pKSV-htrA
into the L. monocytogenes 10403S chromosome and resolution of the plasmid were performed as previously described (3) to create the htrA mutant designated SRL47. Primers RW1 (5'-CGCAAGGCTTTTTCAAACGATAGGGC-3'), specific for the chromosomal region upstream of htrA (but not included in pKSV-htrA
), and RW8 (5'-CCGCGGATCCGTCACGTAAGGATACACCTAGAG-3'), specific for the 3' region of htrA (included in plasmid pKSV-htrA
), were used to confirm by PCR that the htrA deletion was located in the chromosomal htrA locus. The DNA sequence of the chromosomal htrA deletion in SRL47 was determined to be correct by sequencing a PCR fragment generated with primers RW9 and RW10 by using SRL47 chromosomal DNA as a template. The growth rate of the htrA mutant at 44°C, but not at 30°C or 37°C, was greatly decreased (not shown), as has been previously described (24).
The antibiotic puromycin interrupts chain elongation during protein synthesis in bacteria, and this leads to the generation of truncated and misfolded proteins. Accumulation of these peptides can lead to cellular stress. Staphylococcus aureus, Brucella melitensis, and Lactococcus lactis htrA mutants show a higher sensitivity to puromycin-induced stress than wild-type strains, suggesting a role for HtrA in the degradation of the truncated proteins (8, 17, 19). To test whether L. monocytogenes HtrA played a similar role in the degradation of puromycin-induced peptides, 10-fold dilutions of wild-type and htrA mutant cultures (optical density at 600 nm [OD600] = 0.7) were made and spotted onto brain heart infusion (BHI; BD Biosciences, Sparks, MD) agar containing puromycin. A growth defect was noted for most dilutions of the L. monocytogenes htrA mutant when grown at 40°C, but not 30°C, in the presence of 8 µg/ml puromycin (Fig. 1). Another L. monocytogenes serine protease, ClpP, has been shown to be involved in the degradation of puromycin-induced peptides (9). The results shown in Fig. 1 indicate that HtrA plays an important role, in addition to ClpP, in the elimination of abnormal proteins induced by puromycin treatment.
|
|
The intracellular pathogenic lifestyle of listeriae exposes them to many different types of stresses. After adherence and internalization by macrophages, listeriae are taken into the phagosomal compartment, where most of the bacteria are destroyed (6). Only a small fraction of the bacteria are able to escape into the cytosol. During their time in the phagosome, listeriae encounter several antimicrobial compounds, such as nitric oxide, and the products of the respiratory burst, including superoxide radicals (14, 20). These toxic compounds can cause damage to essential proteins, DNA, and other cellular components. Pathogenic bacteria possess many different genetic loci that contribute to their ability to survive in the presence of these toxic compounds (4, 12, 14). htrA is one such locus that, in many gram-negative and gram-positive bacteria, has been shown to be necessary for resistance to oxidative stress. HtrA presumably accomplishes this by ridding the cell of damaged proteins generated as a result of the action of immune cells of the host (12). To determine whether the L. monocytogenes HtrA protein plays a role in resistance to cellular stress caused by oxidants, a paraquat disk diffusion assay was performed. Overnight cultures were diluted 1:300 in BHI before spreading 50 µl of culture on BHI agar. Sterile 6-mm filter disks were placed on the agar plates, 10 µl of 2 M paraquat was added to the disks, and the plates were incubated at either 37°C or 42°C overnight. As shown in Fig. 3, a wider zone of growth inhibition was measured around the htrA mutant. Hence, the HtrA protease is involved in the resistance of L. monocytogenes to oxidative stress caused by superoxide radicals generated by redox-cycling agents such as paraquat.
|
1 log) of spleens compared to wild-type strains (22). To examine the virulence of our L. monocytogenes 10403S htrA mutant, 8-week-old female BALB/c mice (Charles River, five mice per group) were intravenously administered 2 x 104 CFU of wild-type L. monocytogenes 10403S or the htrA deletion strain. After 3 days, mice infected with the htrA mutant looked visibly healthier (i.e., more active, less ruffled) than those infected with wild-type L. monocytogenes. Spleens and livers were removed, tissues were homogenized in 0.2% IGEPAL (Sigma, St. Louis, MO), and serial dilutions of the suspensions were plated on BHI agar medium containing streptomycin. Mice inoculated with the htrA mutant showed an approximately 2-log reduction in the bacterial load in the liver and an approximately 1-log-decreased level of colonization of spleens compared to mice infected with wild-type L. monocytogenes (Fig. 4). Hence, HtrA is required for full virulence of L. monocytogenes 10403S in mice.
|
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Ahn, S. J., J. A. Lemos, and R. A. Burne. 2005. Role of HtrA in growth and competence of Streptococcus mutans UA159. J. Bacteriol. 187:3028-3038. |
| 2. | Borucki, M. K., J. D. Peppin, D. White, F. Loge, and D. R. Call. 2003. Variation in biofilm formation among strains of Listeria monocytogenes. Appl. Environ. Microbiol. 69:7336-7342. |
| 3. | Camilli, A., L. G. Tilney, and D. A. Portnoy. 1993. Dual roles of plcA in Listeria monocytogenes pathogenesis. Mol. Microbiol. 8:143-157.[Medline] |
| 4. | Chakravortty, D., and M. Hensel. 2003. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect. 5:621-627.[CrossRef][Medline] |
| 5. | Clausen, T., C. Southan, and M. Ehrmann. 2002. The HtrA family of proteases: implications for protein composition and cell fate. Mol. Cell 10:443-455.[CrossRef][Medline] |
| 6. | de Chastellier, C., and P. Berche. 1994. Fate of Listeria monocytogenes in murine macrophages: evidence for simultaneous killing and survival of intracellular bacteria. Infect. Immun. 62:543-553. |
| 7. | Diaz-Torres, M. L., and R. R. Russell. 2001. HtrA protease and processing of extracellular proteins of Streptococcus mutans. FEMS Microbiol. Lett. 204:23-28.[CrossRef][Medline] |
| 8. | Foucaud-Scheunemann, C., and I. Poquet. 2003. HtrA is a key factor in the response to specific stress conditions in Lactococcus lactis. FEMS Microbiol. Lett. 224:53-59.[CrossRef][Medline] |
| 9. | Gaillot, O., E. Pellegrini, S. Bregenholt, S. Nair, and P. Berche. 2000. The ClpP serine protease is essential for the intracellular parasitism and virulence of Listeria monocytogenes. Mol. Microbiol. 35:1286-1294.[CrossRef][Medline] |
| 10. | Grundling, A., L. S. Burrack, H. G. Bouwer, and D. E. Higgins. 2004. Listeria monocytogenes regulates flagellar motility gene expression through MogR, a transcriptional repressor required for virulence. Proc. Natl. Acad. Sci. USA 101:12318-12323. |
| 11. | Helloin, E., L. Jansch, and L. Phan-Thanh. 2003. Carbon starvation survival of Listeria monocytogenes in planktonic state and in biofilm: a proteomic study. Proteomics 3:2052-2064.[CrossRef][Medline] |
| 12. | Janssen, R., T. van der Straaten, A. van Diepen, and J. T. van Dissel. 2003. Responses to reactive oxygen intermediates and virulence of Salmonella typhimurium. Microbes Infect. 5:527-534.[CrossRef][Medline] |
| 13. | Koch, S., M. Hufnagel, and J. Huebner. 2004. Treatment and prevention of enterococcal infectionsalternative and experimental approaches. Exp. Opin. Biol. Ther. 4:1519-1531.[CrossRef] |
| 14. | Nathan, C., and M. U. Shiloh. 2000. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 97:8841-8848. |
| 15. | Otto, M. 2004. Quorum-sensing control in Staphylococcia target for antimicrobial drug therapy? FEMS Microbiol. Lett. 241:135-141.[CrossRef][Medline] |
| 16. | Peel, M., W. Donachie, and A. Shaw. 1988. Temperature-dependent expression of flagella of Listeria monocytogenes studied by electron microscopy, SDS-PAGE and Western blotting. J. Gen. Microbiol. 134:2171-2178.[Medline] |
| 17. | Phillips, R. W., P. H. Elzer, and R. M. Roop II. 1995. A Brucella melitensis high temperature requirement A (htrA) deletion mutant demonstrates a stress response defective phenotype in vitro and transient attenuation in the BALB/c mouse model. Microb. Pathog. 19:227-284.[CrossRef][Medline] |
| 18. | Portnoy, D. A., P. S. Jacks, and D. J. Hinrichs. 1988. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J. Exp. Med. 167:1459-1471. |
| 19. | Rigoulay, C., J. M. Entenza, D. Halpern, E. Widmer, P. Moreillon, I. Poquet, and A. Gruss. 2005. Comparative analysis of the roles of HtrA-like surface proteases in two virulent Staphylococcus aureus strains. Infect. Immun. 73:563-572. |
| 20. | Shiloh, M. U., and C. F. Nathan. 2000. Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. Curr. Opin. Microbiol. 3:35-42.[CrossRef][Medline] |
| 21. | Smith, K., and P. Youngman. 1992. Use of a new integrational vector to investigate compartment-specific expression of the Bacillus subtilis spoIIM gene. Biochimie 74:705-711.[Medline] |
| 22. | Stack, H. M., R. D. Sleator, M. Bowers, C. Hill, and C. G. Gahan. 2005. Role for HtrA in stress induction and virulence potential in Listeria monocytogenes. Appl. Environ. Microbiol. 71:4241-4247. |
| 23. | Way, S. S., L. J. Thompson, J. E. Lopes, A. M. Hajjar, T. R. Kollmann, N. E. Freitag, and C. B. Wilson. 2004. Characterization of flagellin expression and its role in Listeria monocytogenes infection and immunity. Cell Microbiol. 6:235-242.[CrossRef][Medline] |
| 24. | Wonderling, L. D., B. J. Wilkinson, and D. O. Bayles. 2004. The htrA (degP) gene of Listeria monocytogenes 10403S is essential for optimal growth under stress conditions. Appl. Environ. Microbiol. 70:1935-1943. |
| 25. | Yarwood, J. M., and P. M. Schlievert. 2003. Quorum sensing in Staphylococcus infections. J. Clin. Invest. 112:1620-1625.[CrossRef][Medline] |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|